vimarsana.com
Home
Live Updates
Mendus will participate in multiple investor and industry co
Mendus will participate in multiple investor and industry co
Mendus will participate in multiple investor and industry conferences in October and announces presentation of ALISON trial update at SITC
Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: LSX...
Related Keywords
France ,
London ,
City Of ,
United Kingdom ,
United States ,
Stockholm ,
Sweden ,
Denmark ,
Copenhagen ,
Køavn ,
San Diego ,
California ,
San Diego Convention Center ,
Paris ,
France General ,
Netherlands ,
Corey Davis ,
Erik Manting ,
Mario Brkulj ,
Lotta Ferm ,
Leopold Bertea ,
Lifesci Advisors ,
Society For The Immunotherapy Of Cancer ,
Nordic Congress ,
Valency Communications ,
Company Update ,
Nasdaq Stockholm ,
Sci Advisors ,
Markets ,